3689 — Guangdong Kanghua Healthcare Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$835.99m
- HK$601.12m
- CNY2.04bn
- 86
- 93
- 89
- 100
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 117 | -26.1 | 129 | 69.3 | 153 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 51.4 | 80.8 | 33.3 | -3.86 | 4.74 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -193 | 77.7 | 21.4 | 5.93 | -98 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 98.2 | 275 | 333 | 221 | 204 |
Capital Expenditures | -219 | -248 | -171 | -135 | -131 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 6.06 | 65.4 | -128 | 52 | 23.2 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -213 | -182 | -299 | -83.2 | -108 |
Financing Cash Flow Items | -22.1 | -153 | 2.95 | -48.4 | -49.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 135 | -138 | 23.3 | -111 | -55.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 20.6 | -44.2 | 57.7 | 27 | 40.8 |